161 related articles for article (PubMed ID: 25999436)
1. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.
Gustafson MP; Lin Y; Bleeker JS; Warad D; Tollefson MK; Crispen PL; Bulur PA; Harrington SM; Laborde RR; Gastineau DA; Leibovich BC; Cheville JC; Kwon ED; Dietz AB
Clin Cancer Res; 2015 Sep; 21(18):4224-33. PubMed ID: 25999436
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
3. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
4. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
5. The CD14
Mengos AE; Gastineau DA; Gustafson MP
Front Immunol; 2019; 10():1147. PubMed ID: 31191529
[TBL] [Abstract][Full Text] [Related]
6. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.
Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J
Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418
[TBL] [Abstract][Full Text] [Related]
8. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
9. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Menetrier-Caux C; Thomachot MC; Alberti L; Montmain G; Blay JY
Cancer Res; 2001 Apr; 61(7):3096-104. PubMed ID: 11306493
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
12. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
[TBL] [Abstract][Full Text] [Related]
13. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.
Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L
Int J Urol; 2013 Oct; 20(10):971-8. PubMed ID: 23421558
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression.
Li M; Zhang G; Zhang X; Lv G; Wei X; Yuan H; Hou J
Med Oncol; 2014 Dec; 31(12):349. PubMed ID: 25416051
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.
Mao Y; Poschke I; Wennerberg E; Pico de Coaña Y; Egyhazi Brage S; Schultz I; Hansson J; Masucci G; Lundqvist A; Kiessling R
Cancer Res; 2013 Jul; 73(13):3877-87. PubMed ID: 23633486
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
[TBL] [Abstract][Full Text] [Related]
17. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
Filipazzi P; Valenti R; Huber V; Pilla L; Canese P; Iero M; Castelli C; Mariani L; Parmiani G; Rivoltini L
J Clin Oncol; 2007 Jun; 25(18):2546-53. PubMed ID: 17577033
[TBL] [Abstract][Full Text] [Related]
18. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.
Gustafson MP; Lin Y; New KC; Bulur PA; O'Neill BP; Gastineau DA; Dietz AB
Neuro Oncol; 2010 Jul; 12(7):631-44. PubMed ID: 20179016
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive CD14
Javeed N; Gustafson MP; Dutta SK; Lin Y; Bamlet WR; Oberg AL; Petersen GM; Chari ST; Dietz AB; Mukhopadhyay D
Oncoimmunology; 2017; 6(1):e1252013. PubMed ID: 28197368
[TBL] [Abstract][Full Text] [Related]
20. Immune independent crosstalk between lymphoma and myeloid suppressor CD14
Zhang ZJ; Bulur PA; Dogan A; Gastineau DA; Dietz AB; Lin Y
Oncoimmunology; 2015 Apr; 4(4):e996470. PubMed ID: 26137410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]